High-Dose Intravenous Immunoglobulin Is Effective in Painful Diabetic Polyneuropathy Resistant to Conventional Treatments. Results of a Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial - Jann, Stefano; Fazio, Raffaella; Cocito, Dario; Toscano, Antonio; Schenone, Angelo; Marfia, Gerolama Alessandra; Antonini, Giovanni; De Toni Franceschini, Luisa; Mazzeo, Anna; Grandis, Marina; Velardo, Daniele; Mataluni, Giorgia; et al. (Pain medicine (Malden, Mass.), 2020)
Keywords: Adult; Aged; Antidepressants; Antiepileptic agents; Clinical trials; Dermatitis; Diabetes; Diabetes mellitus; Diabetic Neuropathies - drug therapy; Diabetic neuropathy; Double-Blind Method; Double-blind studies; Female; Humans; Immunoglobulins; Immunoglobulins, Intravenous - therapeutic use; Immunologic Factors - therapeutic use; Influenza; Intravenous administration; Italy; Male; Middle Aged; Pain; Pain management; Patients; Polyneuropathy; Quality of life; Treatment resistance; Italy; Intravenous Immunoglobulin; Diabetic Painful Polyneuropathy; Clinical Trial; Neuropathic Pain Symptom Inventory (NPSI); Visual Analog Scale (VAS)